These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1561116)

  • 21. Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments.
    Barzen G; Mayr AC; Langer M; Becker R; Cordes M; Zwicker C; Koppenhagen K; Felix R
    Eur J Nucl Med; 1989; 15(1):42-8. PubMed ID: 2917583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunoscintigraphy in the diagnosis of ovarian carcinoma].
    Bendová M; Bakos K; Zivný J
    Ceska Gynekol; 1998 Aug; 63(4):282-7. PubMed ID: 9750402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunoscintigraphy using monoclonal antibodies before second-look surgery in patients suffering from ovarian cancer.
    Pateisky N; Philipp K; Sevelda P; Skodler WD; Enzelsberger H; Hamilton G; Burchell J; Schatten C
    Gynecol Obstet Invest; 1987; 24(3):211-6. PubMed ID: 3692333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computerized tomography of the abdomen and pelvis with peritoneal administration of soluble contrast (IPC-CT) in detection of residual disease for patients with ovarian cancer.
    Frasci G; Contino A; Iaffaioli RV; Mastrantonio P; Conforti S; Persico G
    Gynecol Oncol; 1994 Feb; 52(2):154-60. PubMed ID: 8314132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computed tomography prior to second-look operation in advanced ovarian cancer.
    Goldhirsch A; Triller JK; Greiner R; Dreher E; Davis BW
    Obstet Gynecol; 1983 Nov; 62(5):630-4. PubMed ID: 6621953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunodetection of ovarian cancer.
    Ahlström KR; Hietala SO; Stendahl U; Stigbrand T
    Acta Oncol; 1993; 32(7-8):729-34. PubMed ID: 8305219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunoscintigraphy of gynecologic tumors with 131I-labeled anti-PLAP monoclonal antibodies.
    Riklund KE; Edbom G; Makiya R; Johansson B; Gerdes U; Hietala SO; Ekelund L; Stigbrand T; Stendahl U
    Acta Radiol; 1991 Sep; 32(5):375-80. PubMed ID: 1910991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abdominopelvic computed tomography: evaluation in patients undergoing second-look laparotomy for ovarian carcinoma.
    Brenner DE; Shaff MI; Jones HW; Grosh WW; Greco FA; Burnett LS
    Obstet Gynecol; 1985 May; 65(5):715-9. PubMed ID: 3982750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of abdominopelvic computed tomography results and findings at second-look laparotomy in ovarian carcinoma patients.
    Reuter KL; Griffin T; Hunter RE
    Cancer; 1989 Mar; 63(6):1123-8. PubMed ID: 2917315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive values of CA 125 antigen levels and CT scan in second-look procedures for ovarian cancer.
    Aravantinos D; Michalas S; Papazefkos V; Christoforaki M; Stypsaneli A; Vlachos G; Athanasiadis P
    Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):265-70. PubMed ID: 2227069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computed tomography and second-look surgery in ovarian cancer patients. Correlation, actual role and limitations of CT scan.
    De Rosa V; Mangoni di Stefano ML; Brunetti A; Caraco C; Graziano R; Gallo MS; Maffeo A
    Eur J Gynaecol Oncol; 1995; 16(2):123-9. PubMed ID: 7641739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunoscintigraphy of oncologic tumors].
    Barzen G
    Radiol Diagn (Berl); 1990; 31(3):209-20. PubMed ID: 2367627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer.
    Granowska M; Britton KE; Mather SJ; Lowe DG; Ellison D; Bomanji J; Burchell J; Taylor-Papadimitriou J; Hudson CR; Shepherd JH
    Eur J Nucl Med; 1993 Jun; 20(6):483-9. PubMed ID: 8339731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic alternatives to second look in ovarian cancer.
    Torretta L; Balestreri D; Fasola M; Schinko E; Scorbati E; Tateo S
    Eur J Gynaecol Oncol; 1990; 11(2):145-8. PubMed ID: 2379515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical utility of immunoscintigraphy in managing ovarian cancer.
    Krag DN
    J Nucl Med; 1993 Mar; 34(3 Suppl):545-8. PubMed ID: 8441055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies in ovarian and prostate cancer.
    Neal CE; Swenson LC; Fanning J; Texter JH
    Semin Nucl Med; 1993 Apr; 23(2):114-26. PubMed ID: 8511599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroperative radioimmunodetection of ovarian carcinoma using a hand-held gamma detection probe.
    Ind TE; Granowska M; Britton KE; Morris G; Lowe DG; Hudson CN; Shepherd JH
    Br J Cancer; 1994 Dec; 70(6):1263-6. PubMed ID: 7981086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlative imaging study in the diagnosis of ovarian cancer recurrences. The INSERM Research Network (Nantes, Rennes, Reims, Villejuif, Saclay), France.
    Peltier P; Wiharto K; Dutin JP; Chatal JF; Bourguet P; Liehn JC; Vuillez JP; Hérry JY; Loboguerrero A
    Eur J Nucl Med; 1992; 19(12):1006-10. PubMed ID: 1464352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer.
    Granowska M; Britton KE; Shepherd JH; Nimmon CC; Mather S; Ward B; Osborne RJ; Slevin ML
    J Clin Oncol; 1986 May; 4(5):730-6. PubMed ID: 3701391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for ovarian cancer: the role of noninvasive imaging techniques.
    Cohen CJ; Jennings TS
    Am J Obstet Gynecol; 1994 Apr; 170(4):1088-94. PubMed ID: 8166191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.